RecallDepth
Class II Terminated

Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27

Company
Teva Pharmaceuticals Usa
Recall Initiated
March 5, 2020
Posted
May 13, 2020
Recall Number
D-1260-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
600 cartons/2 auto-injector per carton
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.

Distribution

Product was distributed to 1 wholesaler who still had all units within their possession and had not shipped or further distributed any of the product.

Lot / Code Info

Lot # 007F19AA, exp. date 04/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls